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Liver involvement of some kind is a presenting feature of a number of inherited 
metabolic diseases. One approach to the diagnosis of inherited metabolic diseases 
presenting as hepatic syndrome is to consider four possible presentations, 





Hyperbilirubinemia in infants with classical galactosemia is often initially 
unconjugated, converting only after a period of some days to the conjugated 
hyperbilirubinemia that is widely regarded as characteristic of the disease. 
Conjugated hyperbilirubinemia as a manifestation of inherited metabolic disease 
is more common than unconjugated hyperbilirubinemia because it includes those 
diseases, like galactosemia, hepatorenal tyrosinemia, and hereditary fructose 
intolerance, in which hepatocellular dysfunction is prominent. The hepatomegaly 
associated with inherited metabolic diseases is generally persistent and non-
tender. If the liver is so soft that the edge is difficult to palpate, enlargement 
is likely to be due to accumulation of triglyceride, a typical feature of GSD 
(glycogen storage disease) type I. At the other extreme, a hard and irregular 
liver edge, often associated with only modest enlargement of the organ, is 
characteristic of cirrhosis. When it is enlarged as a result of lysosomal storage, 
the liver is usually firm, but not hard. Is the spleen also enlarged? A history of 
hematemesis or the presence of ascites or abdominal venous dilatation, would 
suggest that splenomegaly is caused by portal hypertension resulting from 
cirrhosis. However, the spleen may be enlarged by infiltration or accumulation 
of the same cells or metabolites causing enlargement of the liver. Besides 
sharing the portal circulation, the liver and spleen both contain components 
of the reticuloendothelial system (RES). Conditions causing expansion of the 
RES, either as a result of cellular proliferation or storage within RES cells (i.e., 
macrophages) commonly present with clinical enlargement of both organs. This 
is characteristic of hepatorenal tyrosinemia (hereditary tyrosinemia, type I). 
Hypoglycemia is caused by the deficiency of enzymes which are involved in 
glycogenolysis, gluconeogenesis and beta oxidation of fatty acids and etc.  The 
presentation of inherited metabolic diseases with onset in the newborn period 
or early infancy as acute hepatocellular disease is characterized in most cases 
by some combination of failure to thrive, mild to severe hyperbilirubinemia, 
hypoglycemia, hyperammonemia, elevated aminotransferases, bleeding 
diathesis, edema, and ascites. Approaching to inherited metabolic diseases is by 
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ruling out infectious diseases and developmental defects and 
doing special laboratory tests for inherited metabolic disorders. 
Management is by drug therapy, bone marrow transplantation, 
liver transplantation and gene therapy.   
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